NEW YORK, Sept. 12, 2023 /PRNewswire/ — The femtech market is expected to grow by USD 38.07 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 12.02% during the forecast period, according to Technavio Research. The market has been segmented by end-user (direct-to-consumer, hospitals, fertility clinics, and others), type (devices, software, services, and others), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). North America is estimated to contribute 49% to the growth of the global market during the forecast period. The growth of the femtech market in the region will likely be driven by the presence of a well-established healthcare system that provides high-quality women’s healthcare facilities through infertility clinics and hospitals. The infertility rate in smokers is twice as high as in non-smokers. In women, the risk of fertility problems increases with the number of cigarettes smoked daily. In addition, the USA was a major revenue contributor to the market in 2022 as the high rate of female infertility and related disorders, such as obesity, is steadily increasing, thereby increasing the cases of infertility in women. Hence, these factors are expected to drive market growth in the region during the forecast period. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read PDF Sample Report
Chiaro Technology Ltd., FemTec Health, Flo Health UK Ltd., HeraMED, Laboratory Corp. of America Holdings, Maven Clinic Co., Natural Cycles Nordic AB, Naya Health, Savantini Ltd., The Flex Co., Tia Inc., Uniq Health Inc., Upward Labs Holdings Inc., Willow Innovations Inc., WOOM Fertility S.L., YS BRANDS PVT. LTD., BioWink GmbH, IBREVE Ltd., NIRAMAI Health Analytix Pvt. Ltd., and Roman Health Ventures Inc.
Chiaro Technology Ltd. – The company offers Femtech products such as electric breast pumps and manual breast pumps, under its brand Elvie.
To gain access to more vendor profiles available with Technavio, buy the report!
FemTech Market: Segmentation Analysis
The market has been segmented by end-user (direct-to-consumer, hospitals, fertility clinics, and others), type (devices, software, services, and others), and geography (North America, Europe, Asia, and the Rest of the World (ROW)).
- The market share growth by the direct-to-consumer segment will be significant during the forecast period. The FemTech companies are mainly technology-based and customer-focused businesses providing solutions for women’s health issues.
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report
“Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021”- Technavio
FemTech Market: Market Dynamics
- Increase in rate of infertility and obesity-related cases in women
- Increasing prevalence of sexual dysfunctions in women
- Increasing focus on digital health solutions
The increasing prevalence of sexual dysfunctions in women is driving growth in the femtech market. Sexual dysfunction is common in women and is associated with loss of desire, difficulty reaching orgasm, and pain during sex. It is believed that the occurrence of sexual dysfunction in women is due to hormonal factors, irregular menstruation, amenorrhea, insufficient vaginal lubrication, and miscarriage. In addition, sexual dysfunction in women can be caused by various chronic diseases, such as diabetes. Diabetes is one of the most common chronic diseases in the world. Furthermore, some clinical manifestations such as overweight, hypertension, obesity, metabolic syndrome, smoking, and atherogenic dyslipidemia may occur in diabetic patients as risk factors for dysfunction. Hence, these factors are expected to drive market growth during the forecast period.
Identify key trends, drivers, and challenges in the market. Download to gain access to this information.
The eClinical solutions market size is estimated to grow by USD 9,654.33 million at a CAGR of 13.47% between 2022 and 2027. This report covers market segmentation by end-user (pharmaceutical and biotechnology companies, contract research organizations, consulting service companies, medical device manufacturers, and others), deployment (cloud-based and on-premises), and geography (North America, Europe, Asia, and Rest of World (ROW)). Rise in clinical trials for drugs driving the growth of the market.
The telemedicine market size is estimated to grow by USD 92.07 billion at a CAGR of 15.64% between 2022 and 2027. This report covers market segmentation by product (services and solutions), application (telehospital and teleclinic, and telephone), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The increasing healthcare cost is driving the growth of the telemedicine market.
What are the key data covered in this femtech market report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the femtech market between 2022 and 2027.
- Precise estimation of the femtech market size and its contribution to the market in focus on the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- A thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the growth of femtech market companies.
Historic Market Sizes
Five Forces Analysis
Market Segmentation by End-User
Market Segmentation by Type
Market Segmentation by Geography
Drivers, Challenges, & Trends
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]